Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc Azioni (VIR) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	235.83% 56.38	16.79	2.639	3.797	62.96
Cost Of Revenue	92.61% 0.059	0.798	0.038	0.022	1.907
Gross Profit	252.22% 56.32	15.99	2.601	3.775	61.05
Operating Expenses	12.00% 136.40	155.00	189.33	218.96	204.42
Benefits Costs and Expenses	11.75% 121.38	137.54	169.26	201.42	206.15
Costs And Expenses	12.42% 136.46	155.80	189.37	218.98	206.33
Operating Income/Loss	42.39% -80.08	-139.02	-186.73	-215.19	-143.37
Nonoperating Income/Loss	17.41% 15.08	18.26	20.11	17.56	0.183
Income/Loss From Continuing Operations Before Tax	46.17% -65.00	-120.76	-166.63	-197.62	-143.19
Income Tax Expense/Benefit	105.77% 0.276	-4.784	-3.213	-2.848	-2.232
Income/Loss From Continuing Operations After Tax	43.71% -65.28	-115.97	-163.41	-194.78	-140.96
Net Income/Loss	43.71% -65.28	-115.97	-163.41	-194.78	-140.96
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-0.056
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	83,901% 135.28	0.161	134.29	134.06	133.55
Diluted Average Shares	83,901% 135.28	0.161	134.29	134.06	133.55
Basic Earnings Per Share	44.19% -0.48	-0.86	-1.22	-1.45	-1.06
Diluted Earnings Per Share	44.19% -0.48	-0.86	-1.22	-1.45	-1.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-0.056